StageBio

At StageBio, we are more than a GLP-compliant histopathology provider — we are your scientific partner in drug development. StageBio supports biopharma and medical device drug developers at every stage of development, from discovery through to regulatory submission. We specialize in histopathology, pathology, specimen archiving, and regulatory reporting — but our true value lies in the insight and guidance we provide to help you de-risk your program and meet regulatory expectations with confidence. Histopathology plays a critical role in demonstrating the safety and efficacy of your candidate therapies and devices. We help you understand and interpret tissue-based findings, offering expert consultation to ensure high-quality, decision-driving data is generated and communicated clearly in your submissions. Whether it's preclinical toxicology, IND-enabling studies, or complex clinical pathology, we act as an extension of your team ensuring scientific rigor, quality, and compliance at every stage of your project. With facilities in the U.S. and Germany and a team of 20+ board-certified veterinary pathologists supported by 100+ trained lab professionals, StageBio offers scalable, global capabilities combined with personalized service. Our integrated services are built to support you in achieving faster development timelines, stronger data packages, and successful regulatory outcomes. 🟣 Services: Consulting | Necropsy | Histology | Imaging | Pathology | Archiving | Submission 🟣 Sites: Frederick, US | Maurertown, US | Freiburg, Germany ☑️ Book a call with our scientific team | Connect with a StageBio expert to discuss your study goals, timelines, and how our pathology support can help you deliver the quality data for your project.